IN SB0282

Restricts administration of abortion-inducing drugs to licensed physicians who must follow FDA drug label protocols, conduct an in-person examination, document gestational age and intrauterine fetal location, and provide the patient with drug label information

Requires the prescribing physician to enter into a contract with another physician who has hospital admitting, gynecological, and surgical privileges to handle any complications from the drug

Mandates a follow-up appointment approximately 14 days after administration to confirm pregnancy termination via ultrasound and assess bleeding, with physicians required to document efforts to ensure patient compliance

Requires physicians to report adverse events (death, hospitalization, disability, birth defects, or other serious complications) to the FDA MedWatch system and the Indiana Medical Licensing Board within 3 days

Establishes violations as a Class A misdemeanor, with additional potential disciplinary sanctions and civil liability for wrongful death and medical malpractice; pregnant women are exempt from penalties